AstraZeneca PLC (LSE:AZN) - Share price - Overview

Stock Report

AstraZeneca PLC AZN

Last Price
GBX4,598.50

Day Change
42.50|0.93%

As of 23/02/2017
09:38:33 GMT | GBX
Minimum 15 Minutes Delay.

Last Close4,556.00p
Day Range4,560.00 - 4,656.35
Mkt Cap57.64Bil
52-Wk Range3,680.00 - 5,505.00
Yield %4.34
ISINGB0009895292
Volume310,470
P/E23.81
P/S3.59
P/CF25.76

Share Price

Total Returns 22/02/2017

 Chg (%)  
More ...
AstraZeneca PLC8.98 
FTSE 100 TR GBP1.85
 
Financials
201420152016
More ...
Income Statement
Turnover16,124.3816,172.13-
Operating Profit1,297.992,692.74-
Net Profit750.131,849.70-
Reported EPS59.52145.96-
Balance Sheet
Current Assets10,708.2910,860.27-
Non Current Assets26,870.4429,932.06-
Total Assets37,578.7340,792.33-
Current Liabilities11,114.2510,088.17-
Total Liabilities24,979.1628,234.53-
Total Equity12,599.5712,557.80-
Cash Flow
Operating Cash Flow5,340.173,386.54-
Net Change in Cash-1,627.20-24.22-
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20174,480.23310.6260.8414.670.24227.575.00
20184,947.04372.3119.8612.240.62233.425.12

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
16/12/2016Transfer OutMr. Pascal Soriot0.0056,9510.00
27/10/2016PurchaseMr. Graham Chipchase4,807.951004,808.00
01/08/2016PurchaseMr. Marc Dunoyer5,048.0043,7302,207,490.00
13/06/2016SaleMr. Pascal Soriot3,852.0084,3163,247,852.00

Company Profile

AstraZeneca PLC is a biopharmaceutical company. It is engaged in the discovery and development of new products, which are then manufactured, marketed and sold.

Sector

Drug Manufacturers - Major

Market Position

8 of 1852 Companies

Index

FTSE 100 ,FTSE 350 ,FTSE Eurotop 100 ,S&P Europe 350 ,Eurotop 300

Outlook

(02/02/2017) no outlook statement

Next Event 08/03/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)14.2614.3716.15
Div Yld (E)5.013.764.04
PEG (E)0.27-0.441.25
ROCE0.00202.18-29.76
Op Mrgn0.00-11.85-30.74
EPS Grwth52.0440.3438.65
Dividends
PreviousLatest
More ...
Record Date12/08/1617/02/17
Ex-Div11/08/1616/02/17
Paid12/09/1620/03/17
Amnt68.70150.20

Broker Sentiment

Strong Buy0
Buy3
Hold2
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Leif Johansson
Chief Executive OfficerMr. Pascal Soriot
Chief Financial OfficerMr. Marc Dunoyer
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.